Shanghai Newsummit Biopharma and HandInScan Sign Agreement to Validate and Commercialize Infection Control Technology in China

Sep 12, 2016, 08:10 ET from DBH Investment

SHANGHAI and LONDON, September 12, 2016 /PRNewswire/ --

Shanghai Newsummit Biopharma and HandInScan - an innovative infection control technology company - signed an agreement today to introduce the HandInScan technology in China through validating with leading hospitals and key opinion leaders. The signing took place at the Wenzhou Biomedical Innovation Center Healthcare Forum held during the week of the China G20 Summit in the presence of Mr. Dai Tao, Deputy Director of the Development Center for Medical Science & Technology of the National Health & Family Planning Commission, and Mr. Zhang Geng, Mayor of Wenzhou.

     (Logo: http://photos.prnewswire.com/prnh/20160210/331945LOGO )

The HandInScan Technology is the only quality-assured system focusing on hand disinfection quality control that can objectively determine hand hygiene effectiveness. The system is designed to teach and verify if protocols are followed properly.

Infectious diseases are a significant threat to patients worldwide including China and have a burden on healthcare spending. Among them healthcare associated infections affect 2-3% of the patients which can be significantly reduced with proper hand washing compliance and technique following the WHO guidelines. HandInScan brings that much needed hand hygiene education and control to an everyday practice integrating with the hospital's quality control system.

Dr. Jun Ren, CEO of Shanghai Newsummit Biopharma, said "We are proud to form an alliance with HandinScan, since their technology can deliver an effective solution to healthcare organisations.  The technology is now utilized in over 20 countries worldwide, and healthcare organizations implementing the HandInScan technology are seeing the effect of patient safety and provider benefits that the system can deliver.  We believe the healthcare system in China and Chinese patients can also benefit from this innovation."

Peter Rona, CEO of HandinScan added: "We believe that Newsummit is the right organization to bring healthcare related innovation into China. This partnership is an important milestone in our commercial strategy. We look forward to working with Newsummit in bringing the benefits of the systems to Chinese hospitals."

About HandInScan

HandInScan Kft. is a health-tech company focusing on the unmet and critical need of reducing healthcare-associated infections.

About Newsummit

Newsummit Biopharma is one of China's most prominent healthcare resource integrators, providing a full range of market entry/regulatory services to international and domestic companies, with unrivaled access to top clinical KOLs nationwide.


SOURCE DBH Investment